These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 29776604)

  • 1. Biased Agonism/Antagonism of Cardiovascular GPCRs for Heart Failure Therapy.
    Desimine VL; McCrink KA; Parker BM; Wertz SL; Maning J; Lymperopoulos A
    Int Rev Cell Mol Biol; 2018; 339():41-61. PubMed ID: 29776604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-arrestin biased agonism/antagonism at cardiovascular seven transmembrane-spanning receptors.
    Lymperopoulos A
    Curr Pharm Des; 2012; 18(2):192-8. PubMed ID: 22229558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arrestins in the Cardiovascular System: An Update.
    Lymperopoulos A
    Prog Mol Biol Transl Sci; 2018; 159():27-57. PubMed ID: 30340788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent updates on GPCR biased agonism.
    Pupo AS; Duarte DA; Lima V; Teixeira LB; Parreiras-E-Silva LT; Costa-Neto CM
    Pharmacol Res; 2016 Oct; 112():49-57. PubMed ID: 26836887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biased signaling of G protein coupled receptors (GPCRs): Molecular determinants of GPCR/transducer selectivity and therapeutic potential.
    Seyedabadi M; Ghahremani MH; Albert PR
    Pharmacol Ther; 2019 Aug; 200():148-178. PubMed ID: 31075355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biased agonism/antagonism at the AngII-AT1 receptor: Implications for adrenal aldosterone production and cardiovascular therapy.
    Maning J; Negussie S; Clark MA; Lymperopoulos A
    Pharmacol Res; 2017 Nov; 125(Pt A):14-20. PubMed ID: 28511989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biased agonism at G protein-coupled receptors: the promise and the challenges--a medicinal chemistry perspective.
    Shonberg J; Lopez L; Scammells PJ; Christopoulos A; Capuano B; Lane JR
    Med Res Rev; 2014 Nov; 34(6):1286-330. PubMed ID: 24796277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging structural insights into biased GPCR signaling.
    Shukla AK; Singh G; Ghosh E
    Trends Biochem Sci; 2014 Dec; 39(12):594-602. PubMed ID: 25458114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fulfilling the Promise of "Biased" G Protein-Coupled Receptor Agonism.
    Luttrell LM; Maudsley S; Bohn LM
    Mol Pharmacol; 2015 Sep; 88(3):579-88. PubMed ID: 26134495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tango assay for ligand-induced GPCR-β-arrestin2 interaction: Application in drug discovery.
    Dogra S; Sona C; Kumar A; Yadav PN
    Methods Cell Biol; 2016; 132():233-54. PubMed ID: 26928547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arrestins in the cardiovascular system.
    Lymperopoulos A; Bathgate A
    Prog Mol Biol Transl Sci; 2013; 118():297-334. PubMed ID: 23764059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biased receptor functionality versus biased agonism in G-protein-coupled receptors.
    Franco R; Aguinaga D; Jiménez J; Lillo J; Martínez-Pinilla E; Navarro G
    Biomol Concepts; 2018 Dec; 9(1):143-154. PubMed ID: 30864350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biasing GPCR signaling from inside.
    Shukla AK
    Sci Signal; 2014 Jan; 7(310):pe3. PubMed ID: 24473194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inverse agonism: the classic concept of GPCRs revisited [Review].
    Sato J; Makita N; Iiri T
    Endocr J; 2016 Jun; 63(6):507-14. PubMed ID: 26961122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel insights into biased agonism at G protein-coupled receptors and their potential for drug design.
    Martí-Solano M; Guixà-González R; Sanz F; Pastor M; Selent J
    Curr Pharm Des; 2013; 19(28):5156-66. PubMed ID: 23621547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G Protein-coupled Receptor Biased Agonism.
    Hodavance SY; Gareri C; Torok RD; Rockman HA
    J Cardiovasc Pharmacol; 2016 Mar; 67(3):193-202. PubMed ID: 26751266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biased G protein-coupled receptor agonism mediates Neu1 sialidase and matrix metalloproteinase-9 crosstalk to induce transactivation of insulin receptor signaling.
    Haxho F; Haq S; Szewczuk MR
    Cell Signal; 2018 Mar; 43():71-84. PubMed ID: 29277445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elucidating structural and molecular mechanisms of β-arrestin-biased agonism at GPCRs via MS-based proteomics.
    Xiao K; Sun J
    Cell Signal; 2018 Jan; 41():56-64. PubMed ID: 28939107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. βArrestins in cardiac G protein-coupled receptor signaling and function: partners in crime or "good cop, bad cop"?
    Lymperopoulos A; Negussie S
    Int J Mol Sci; 2013 Dec; 14(12):24726-41. PubMed ID: 24351844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biased agonism: An emerging paradigm in GPCR drug discovery.
    Rankovic Z; Brust TF; Bohn LM
    Bioorg Med Chem Lett; 2016 Jan; 26(2):241-250. PubMed ID: 26707396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.